BOXED O
WARNING O
: O
WARNING O
: O
RISK O
OF O
SERIOUS O
CARDIOVASCULAR O
AND O
GASTROINTESTINAL O
EVENTS O
WARNING O
: O
RISK O
OF O
SERIOUS O
CARDIOVASCULAR O
AND O
GASTROINTESTINAL O
EVENTS O
EXCERPT O
: O
WARNING O
: O
RISK O
OF O
SERIOUS O
CARDIOVASCULAR O
AND O
GASTROINTESTINAL O
EVENTS O
See O
full O
prescribing O
information O
for O
complete O
boxed O
warning O
. O

* O
Nonsteroidal O
anti-inflammatory O
drugs O
( O
NSAIDs O
) O
cause O
an O
increased O
risk O
of O
serious O
cardiovascular O
thrombotic O
events O
, O
including O
myocardial O
infarction O
, O
and O
stroke O
, O
which O
can O
be O
fatal O
This O
risk O
may O
occur O
early O
in O
treatment O
and O
may O
increase O
with O
duration O
of O
use O
( O
5.1 O
) O
* O
PENNSAID O
is O
contraindicated O
in O
the O
setting O
of O
coronary O
artery O
bypass O
graft O
( O
CABG O
) O
surgery O
( O
4 O
, O
5.1 O
) O
* O
NSAIDs O
cause O
an O
increased O
risk O
of O
serious O
gastrointestinal O
( O
GI O
) O
adverse O
events O
including O
bleeding O
, O
ulceration O
, O
and O
perforation O
of O
the O
stomach O
or O
intestines O
, O
which O
can O
be O
fatal O
. O

These O
events O
can O
occur O
at O
any O
time O
during O
use O
and O
without O
warning O
symptoms O
. O

Elderly O
patients O
and O
patients O
with O
a O
prior O
history O
of O
peptic O
ulcer O
disease O
and/or O
GI O
bleeding O
are O
at O
greater O
risk O
for O
serious O
GI O
events O
( O
5.2 O
) O
Cardiovascular O
Thrombotic O
Events O
* O
Nonsteroidal O
anti-inflammatory O
drugs O
( O
NSAIDs O
) O
cause O
an O
increased O
risk O
of O
serious O
cardiovascular B-OSE_Labeled_AE
thrombotic I-OSE_Labeled_AE
events I-OSE_Labeled_AE
, O
including O
myocardial B-OSE_Labeled_AE
infarction I-OSE_Labeled_AE
, O
and O
stroke B-OSE_Labeled_AE
, O
which O
can O
be O
fatal B-NonOSE_AE
. O

This O
risk O
may O
occur O
early O
in O
treatment O
and O
may O
increase O
with O
duration O
of O
use O
. O

[ O
see O
Warnings O
and O
Precautions O
( O
5.1 O
) O
] O
. O

* O
PENNSAID O
is O
contraindicated O
in O
the O
setting O
of O
coronary O
artery O
bypass O
graft O
( O
CABG O
) O
surgery O
[ O
see O
Contraindications O
( O
4 O
) O
and O
Warnings O
and O
Precautions O
( O
5.1 O
) O
] O
. O

Gastrointestinal O
Bleeding O
, O
Ulceration O
, O
and O
Perforation O
* O
NSAIDs O
cause O
an O
increased O
risk O
of O
serious O
gastrointestinal B-OSE_Labeled_AE
( I-OSE_Labeled_AE
GI I-OSE_Labeled_AE
) I-OSE_Labeled_AE
adverse O
events O
including O
bleeding I-OSE_Labeled_AE
, O
ulceration O
, O
and O
perforation B-OSE_Labeled_AE
of I-OSE_Labeled_AE
the I-OSE_Labeled_AE
stomach O
or O
intestines I-OSE_Labeled_AE
, O
which O
can O
be O
fatal B-NonOSE_AE
. O

These O
events O
can O
occur O
at O
any O
time O
during O
use O
and O
without O
warning O
symptoms O
. O

Elderly O
patients O
and O
patients O
with O
a O
prior O
history O
of O
peptic B-Not_AE_Candidate
ulcer I-Not_AE_Candidate
disease I-Not_AE_Candidate
and/or O
GI B-Not_AE_Candidate
bleeding I-Not_AE_Candidate
are O
at O
greater O
risk O
for O
serious O
GI B-NonOSE_AE
events I-NonOSE_AE
[ O
see O
Warnings O
and O
Precautions O
( O
5.2 O
) O
] O
. O

